Ikapharmindo Putramas Tbk. vs Merck Tbk. — how do they compare? Ikapharmindo Putramas Tbk. trades at Rp183 (market cap 308.29B), while Merck Tbk. trades at Rp3,800 (market cap 1.7T). The key difference: Merck Tbk. is far larger — about 5.5× Ikapharmindo Putramas Tbk.'s market cap. Which is the better fit depends on your goals.
| IKPM | MERK | |
|---|---|---|
Market Cap | 308.29B | 1.7T |
Indicative Equilibrium Price | 183 | 3,850 |
Indicative Equilibrium Volume | 1 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Ikapharmindo Putramas Tbk (the “Company") was established under the name of PT Ikapharm Indonesia based on Notarial Deed of Lien Tanudirdja, S.H., No. 63 dated May 18, 1978. The Company started its commercial operations in 1978. PT Ikapharma Inti Mas is the Parent Company of the Company.
Read more on IKPM →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →